176
Views
9
CrossRef citations to date
0
Altmetric
Comprehensive Reviews

Dose-response relation between serum total cholesterol levels and overall cancer risk: evidence from 12 prospective studies involving 1,926,275 participants

, , , &
Pages 432-441 | Received 10 Jul 2018, Accepted 20 Sep 2018, Published online: 27 Nov 2018

References

  • Ahn J, Lim U, Weinstein SJ, Schatzkin A, Hayes RB, Virtamo J, Albanes D. 2009. Prediagnostic total and high-density lipoprotein cholesterol and risk of cancer. Cancer Epidemiol Biomarkers Prev. 18:2814–2821.
  • Bekkering GE, Harris RJ, Thomas S, Mayer AM, Beynon R, Ness AR, Harbord RM, Bain C, Smith GD, Sterne JA. 2008. How much of the data published in observational studies of the association between diet and prostate or bladder cancer is usable for meta-analysis? Am J Epidemiol. 167:1017–1026.
  • Chen H, Qin S, Wang M, Zhang T, Zhang S. 2015. Association between cholesterol intake and pancreatic cancer risk: evidence from a meta-analysis. Sci Rep 5:8243.
  • Chiavarini M, Bertarelli G, Minelli L, Fabiani R. 2017. Dietary intake of meat cooking-related mutagens (HCAs) and risk of colorectal adenoma and cancer: a systematic review and meta-analysis. Nutrients. 9:514.
  • Egger M, Davey SG, Schneider M, Minder C. 1997. Bias in meta-analysis detected by a simple, graphical test. BMJ. 315:629–634.
  • Gabitova L, Gorin A, Astsaturov I. 2014. Astsaturov Molecular pathways: sterols and receptor signaling in cancer. Clin Cancer Res. 20:28–34.
  • Greenland S, Longnecker MP. 1992. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol. 135:1301–1309.
  • Grosso G, Bella F, Godos J, Sciacca S, Del Rio D, Ray S, Galvano F, Giovannucci EL. 2017. Possible role of diet in cancer: systematic review and multiple meta-analyses of dietary patterns, lifestyle factors, and cancer risk. Nutr Rev. 75:405–419.
  • Guan XM, Wu SL, Yang XL, Han X, Yang YH, Li XT, Bin Waleed K, Yue D, Zhan SY, Liu Y, et al. 2018. Association of total cholesterol, low-density lipoprotein cholesterol, and non-high-density lipoprotein cholesterol with atherosclerotic cardiovascular disease and cancer in a Chinese male population. Int J Cancer. 142:1209–1217.
  • Guo J, Wei W, Zhan L. 2015. Red and processed meat intake and risk of breast cancer: a meta-analysis of prospective studies. Breast Cancer Res Treat. 151:191–198.
  • Hamling J, Lee P, Weitkunat R, Ambühl M. 2008. Facilitating meta-analyses by deriving relative effect and precision estimates for alternative comparisons from a set of estimates presented by exposure level ordisease category. Stat Med. 27:954–970.
  • Hashmi S, Wang Y, Suman DS, Parhar RS, Collison K, Conca W, Al-Mohanna F, Gaugler R. 2015. Human cancer: is it linked to dysfunctional lipid metabolism? Biochim Biophys Acta. 1850:352–364.
  • Higgins JP, Thompson SG, Deeks JJ, Altman DG. 2003. Measuring inconsistency in meta-analyses. BMJ. 327:557–560.
  • His M, Zelek L, Deschasaux M, Pouchieu C, Kesse-Guyot E, Hercberg S, Galan P, Latino-Martel P, Blacher J, Touvier M. 2014. Prospective associations between serum biomarkers of lipid metabolism and overall, breast and prostate cancer risk. Eur J Epidemiol. 29:119–132.
  • Iso H, Ikeda A, Inoue M, Sato S, Tsugane S, JPHC Study Group. 2009. Serum cholesterol levels in relation to the incidence of cancer: the JPHC study cohorts. Int J Cancer. 125:2679–2686.
  • Kitahara CM, Berrington de González A, Freedman ND, Huxley R, Mok Y, Jee SH, Samet JM. 2011. Total cholesterol and cancer risk in a large prospective study in Korea. J Clin Oncol. 29:1592–1598.
  • Kwiterovich PO Jr. 2000. The metabolic pathways of high-density lipoprotein, low-density lipoprotein, and triglycerides: a current review. Am J Cardiol. 86:5L–10L.
  • Lin X, Lu L, Liu L, Wei S, He Y, Chang J, Lian X. 2017. Blood lipids profile and lung cancer risk in a meta-analysis of prospective cohort studies. J Clin Lipidol 11:1073–1081.
  • Lin X, Liu L, Fu Y, Gao J, He Y, Wu Y, Lian X. 2018. Dietary cholesterol intake and risk of lung cancer: a meta-analysis. Nutrients. 10:185.
  • Ni H, Liu H, Gao R. 2015. Serum lipids and breast cancer risk: a meta-analysis of prospective cohort studies. PLoS One 10:e0142669.
  • Orsini N, Li R, Wolk A, Khudyakov P, Spiegelman D. 2012. Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. Am J Epidemiol. 175:66–73.
  • Orsini N, Bellocco R, Greenland S. 2006. Generalized least squares for trend estimation of summarized dose-response data. Stata J. 6:40–57.
  • Rong Y, Chen L, Zhu T, Song Y, Yu M, Shan Z, Sands A, Hu F, Liu L. 2013. Egg consumption and risk of coronary heart disease and stroke: dose-response meta-analysis of prospective cohort studies. BMJ. 346:e8539.
  • Schatzkin A, Hoover RN, Taylor PR, Ziegler RG, Carter CL, Albanes D, Larson DB, Licitra LM. 1988. Site-specific analysis of total serum cholesterol and incident cancer in the National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study. Cancer Res. 48:452–458.
  • Stemmermann GN, Chyou PH, Kagan A, Nomura AM, Yano K. 1991. Serum cholesterol and mortality among Japanese-American men. The Honolulu (Hawaii) Heart Program. Arch Intern Med. 151:969–972.
  • Strohmaier S, Edlinger M, Manjer J, Stocks T, Bjørge T, Borena W, Häggström C, Engeland A, Nagel G, Almquist M, et al. 2013. Total serum cholesterol and cancer incidence in the metabolic syndrome and Cancer Project (Me-Can). PLoS One. 8:e54242.
  • Sun H, Yuan Y, Wang P, Cai R, Xia W, Huang R, Wang S. 2015. Intensified low-density lipoprotein-cholesterol target of statin therapy and cancer risk: a meta-analysis. Lipids Health Dis. 14:140.
  • Torre LA, Siegel RL, Ward EM, Jemal A. 2016. Global cancer incidence and mortality rates and trends-an update. Cancer Epidemiol Biomarkers Prev. 25:16–27.
  • Touvier M, Fassier P, His M, Norat T, Chan DS, Blacher J, Hercberg S, Galan P, Druesne-Pecollo N, Latino-Martel P. 2015. Cholesterol and breast cancer risk: a systematic review and meta-analysis of prospective studies. Br J Nutr. 114:347–357.
  • Williams RR, Sorlie PD, Feinleib M, McNamara PM, Kannel WB, Dawber TR. 1981. Cancer incidence by levels of cholesterol. JAMA. 245:247–252.
  • Yang K, Marley A, Tang H, Song Y, Tang JY, Han J. 2017. Statin use and non-melanoma skin cancer risk: a meta-analysis of randomized controlled trials and observational studies. Oncotarget. 8:75411–75417.
  • Yao X, Tian Z. 2015. Dyslipidemia and colorectal cancer risk: a meta-analysis of prospective studies. Cancer Causes Control. 26:257–268.
  • YuPeng L, YuXue Z, PengFei L, Cheng C, YaShuang Z, DaPeng L, Chen D. 2015. Cholesterol levels in blood and the risk of prostate cancer: a meta-analysis of 14 prospective studies. Cancer Epidemiol Biomarkers Prev. 24:1086–1093.
  • Zhang J, Yu KF. 1998. What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA. 280:1690–1691.
  • Zhao W, Guan J, Horswell R, Li W, Wang Y, Wu X, Hu G. 2014. HDL cholesterol and cancer risk among patients with type 2 diabetes. Diabetes Care. 37:3196–3203.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.